Elbrus Race Anatoly, Valery and Alexandr gone as well and Elbrus Race of the first edition has stopped. Taking into consideration the increase of the popularity of extreme sport and mountaineering in Russia, the accommodation convenience in Elbrus region, the experience in organization of sport events, Russianclimb.com and Top Sport Travel (high venture travel company, led by Nikolay Shustrov (Master of Sports in mountaineering, member of Balyberdin climbing team, 1990 Elbrus Race participant with 5-th result -2h12min, Camel Trophy 93 participant) decided to reborn the tradition of speed climb competitions to the highest Europe point. So since 2005 second edition is going
MT-45 States the DEA placed MT-45 in Schedule 1 of the Controlled Substance Act. This took effect January 12, 2018. MT-45 MT-45 (IC-6) is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. It is chemically a 1-substituted-4-(1,2-diphenylethyl)piperazine derivative, which is structurally unrelated to most other opioid drugs. Racemic MT-45 has around 80% the potency of morphine, with almost all opioid activity residing in the (S) enantiomer (the opposite stereochemistry from the related drug lefetamine). It has been used as a lead compound from which a large family of potent opioid drugs have been developed, including full agonists,